Emergence of MRSA in positive blood cultures from patients with febrile neutropenia—a cause for concern
Emergence of MRSA in positive blood cultures from patients with febrile neutropenia—a cause for concern
复制标题
发热性中性粒细胞减少症患者血培养阳性中出现 MRSA——值得关注
DOI:
10.1007/s00520-007-0398-5
复制
发表时间:
2008
影响因子:
3.1
通讯作者:
H. Humphreys
中科院分区:
文献类型:
--
作者:
P. Morris;T. Hassan;M. McNamara;Astrid S Hassan;R. Wiig;L. Grogan;O. Breathnach;E. Smyth;H. Humphreys
Goals of workFebrile neutropenia (FN) causes considerable morbidity in patients on cytotoxic chemotherapy. Recently, there has been a trend towards fewer Gram-negative and more Gram-positive infections with increasing antibiotic resistance. To assess these patterns, data from a supra-regional cancer centre in Ireland were reviewed.Patients and methodsA 5-year review of all positive blood cultures in patients undergoing anti-cancer chemotherapy was carried out.Main resultsEight hundred and ninety-four patients were reviewed. The mean incidence of FN was 64.2 cases per year. Eight hundred and forty-six blood culture specimens were taken and 173 (20.4%) were culture positive. The isolated organisms were Gram positive (71.1%), Gram negative (27.8%) and fungal (1.1%). Of the Gram-positive organisms, 75.6% were staphylococci. Of these, 67.8% were coagulase-negative staphylococci and 30.1% wereStaphylococci aureus. Amongst theS.aureus, 89.3% were methicillin-resistant (MRSA). Vancomycin-resistant enterococci were not identified as a cause of positive blood cultures.ConclusionsAmongst patients with cancer who develop FN in our hospital, Gram-positive bacteria account for the largest proportion. The high proportion of MRSA as a cause of positive blood cultures is of concern.